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1  | INTRODUCTION
Bacterial cross‐resistance can be defined as resistance to multiple 
distinct antimicrobial agents conferred by a single molecular mech‐
anism. It occurs when antimicrobials share a route of access to the 
cytoplasm, bind the same target or are involved in the same path‐
way leading to the inhibition of growth or cell death (Baker‐Austin, 
Wright, Stepanauskas, & McArthur, 2006). This phenomenon is 
best described in the context of shared resistance between differ‐
ent clinical antibiotic classes (Sanders, Sanders, Goering, & Werner, 
1984), between antibiotics and disinfectants, biocides or solvents 
(Chapman, 2003; Chuanchuen et al., 2001; Fernandes, Ferreira, & 
Cabral, 2003) and between antibiotics and heavy metals (Baker‐
Austin et al., 2006). An example of cross‐resistance is the efflux 
system AcrAB–TolC which confers resistance to multiple classes 
of antimicrobials but also to metals, dyes and detergents (Anes, 
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Abstract
Bacteria interact with a multitude of other organisms, many of which produce antimi‐
crobials. Selection for resistance to these antimicrobials has the potential to result in 
resistance to clinical antibiotics when active compounds target the same bacterial 
pathways. The possibility of such cross‐resistance between natural antimicrobials 
and antibiotics has to our knowledge received very little attention. The antimicrobial 
activity of extracts from seaweeds, known to be prolific producers of antimicrobials, 
is here tested against Staphylococcus aureus isolates with varied clinical antibiotic re‐
sistance profiles. An overall effect consistent with cross‐resistance is demonstrated, 
with multidrug‐resistant S. aureus strains being on average more resistant to seaweed 
extracts. This pattern could potentially indicate that evolution of resistance to anti‐
microbials in the natural environment could lead to resistance against clinical antibi‐
otics. However, patterns of antimicrobial activity of individual seaweed extracts vary 
considerably and include collateral sensitivity, where increased resistance to a par‐
ticular antibiotic is associated with decreased resistance to a particular seaweed ex‐
tract.	 Our	 correlation‐based	 methods	 allow	 the	 identification	 of	 antimicrobial	
extracts bearing most promise for downstream active compound identification and 
pharmacological testing.
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McCusker,	Fanning,	&	Martins,	2015).	It	is	increasingly	realized	that	
bacterial exposure to anthropogenic antimicrobials in wastewater, 
agricultural settings or the built environment, has the potential to 
co‐select for resistance to clinical antibiotics and significantly con‐
tribute to the rise of antibiotic‐resistant pathogens (Wellington et al., 
2013). However, the potential of the natural environment to co‐se‐
lect for antibiotic resistance has received little attention (Allen et al., 
2010). As the genetic mechanisms conferring antibiotic resistance 
are ancient and many of the selective forces that can promote the 
spread of these mechanisms are potentially nonanthropogenic, this 
is of concern.
One	 potential	 avenue	 of	 selection	 for	 antibiotic	 resistance	 in	
the natural environment is selection for resistance driven by antimi‐
crobial‐producing organisms. Virtually all organisms, from bacteria 
to humans, produce antimicrobial compounds (Raaijmakers, Vlami, 
&	De	Souza,	2002;	Zasloff,	2002).	The	ubiquity	of	interactions	be‐
tween bacteria and antimicrobial producers offers great potential 
for the molecular diversification of bacterial resistance mechanisms, 
a subset of which might also confer resistance to clinical antibiotics. 
To our knowledge, there have been no previous investigations into 
the level of cross‐resistance of natural antimicrobials with clinical 
antibiotics. This lack of data is problematic as environmental reser‐
voirs of resistant bacteria or resistance genes could make their way 
back into the clinic or community and cause hard‐to‐treat infections.
The opposite effect of cross‐resistance is collateral sensitivity, 
where pleiotropic effects cause resistance to natural antimicrobials 
to be negatively correlated with resistance to antibiotics (Pál, Papp, 
&	 Lázár,	 2015).	 One	 example	 is	 the	 evolution	 of	 aminoglycoside	
resistance through mutations resulting in a reduction in the pro‐
ton‐motive force, leading to a diminished activity of efflux pumps 
involved	in	resistance	to	a	range	of	other	antibiotics	classes	(Lázár	
et al., 2013). Such trade‐offs between two antimicrobials can be ex‐
ploited for clinical use in the form of combination therapy (Pál et al., 
2015).	Optimizing	discovery	strategies	for	novel	antimicrobials	that	
display collateral sensitivity with clinical antibiotics could be a prom‐
ising strategy to combat multidrug‐resistant bacterial pathogens.
We here use pathogenic Staphylococcus aureus isolates and sea‐
weeds as a model for cross‐resistance and collateral sensitivity be‐
tween clinical antibiotics and natural antimicrobials. S. aureus is an 
opportunistic pathogen, and strains resistant to multiple antibiotics 
(including methicillin [MRSA] [12]) are causing increased mortality 
and	costs	of	care	(De	Kraker,	Davey,	&	Grundmann,	2011;	Macedo‐
Viñas	et	al.,	2013;	Rubio‐Terrés,	Garau,	Grau,	&	Martinez‐Martinez,	
2010). Seaweeds (or “macroalgae”) form a diverse and abundant 
component of coastal ecosystems. Seaweeds lack cell‐based im‐
mune responses but are continually exposed to a large variety of 
potentially harmful microorganisms present in seawater. It has 
therefore	been	hypothesized	that	they	commonly	exhibit	antimicro‐
bial activity to prevent fouling and disease (Goecke, Labes, Wiese, 
&	 Imhoff,	 2010;	 Plouguerne,	 Hellio,	 Deslandes,	 Véron,	 &	 Stiger‐
Pouvreau,	2008;	Weinberger,	2007).	A	large	number	of	studies	have	
demonstrated that extracts of many seaweed species are able to 
kill or inhibit Gram‐positive and Gram‐negative bacteria, including 
nonmarine human pathogens such as S. aureus	(e.g.,	Horikawa,	Noro,	
& Kamei, 1999; Pierre et al., 2011).
We pair a large set of diverse S. aureus strains isolated from 
human	 infections	with	 extensively	 characterized	 clinical	 antibiotic	
resistance	spectra	to	a	collection	of	seaweed	extracts.	We	use	quan‐
titative measures of susceptibility, allowing detailed correlation anal‐
yses on the efficacy of antimicrobial extracts. We first test whether 
multidrug‐resistant bacterial display greater on average levels of 
resistance to seaweed extracts. We next analyse patterns indica‐
tive of cross‐resistance and collateral sensitivity between individual 
extracts	and	clinical	antibiotics.	Our	results	both	shed	 light	on	the	
potential of macroalgae to select for antibiotic resistance in the bac‐
teria that settle on them and have the potential to inform strategies 
of natural product discovery.
2  | MATERIAL AND METHODS
2.1 | Seaweed extracts
Seaweeds were collected along the southwest coast of Cornwall 
(UK). Intertidal species were collected at low tide, with subtidal spe‐
cies retrieved by scuba diving. Seaweeds were carefully inspected, 
and epiphytes and necrotic areas were removed, followed by rins‐
ing with ddH20. Washed samples were sealed in individual bags and 
stored	at	−20°C	until	extraction.	Samples	were	 lyophilized	using	a	
freeze	drier	(Scanvac,	Labogene,	Lynge,	Denmark)	and	ground	using	
a	 household	 spice	 grinder	 (James	 Martin	 ZX809X).	 The	 resulting	
powder	was	mixed	with	60%	methanol	(5	g	in	50	ml)	and	incubated	
for	2	hr	at	40°C	at	100	rpm.	After	extraction,	samples	were	centri‐
fuged at 1,000 g	for	15	min,	after	which	the	supernatant	was	evap‐
orated	and	resuspended	to	a	 final	volume	of	5	ml	 in	a	 fume	hood.	
Concentrated	extract	was	aliquoted	and	stored	at	−80°C	until	fur‐
ther use.
2.2 | Bacterial strains
Twenty‐eight pathogenic Staphylococcus aureus isolates were ob‐
tained from the Royal Cornwall Hospital in Truro (UK). VITEK 2 AST 
(bioMérieux, Marcy‐l’Étoile, France) data detailing antibiotic suscep‐
tibility were provided for each strain after removing patient data. 
Individual	colonies	were	picked	and	cultured	in	5	ml	LB	broth	(37°C,	
100	rpm)	and	stored	as	20%	glycerol	freezer	stocks	at	−80°C.
2.3 | Kirby‐Bauer disc diffusion assay
A	 Kirby‐Bauer	 disc	 diffusion	 assay	 (Bauer,	 Perry,	 &	 Kirby,	 1959)	
was performed using overnight cultures (18 hr) diluted in broth to 
a	turbidity	equivalent	to	a	McFarland	standard	(Andrews,	2013)	of	
0.5	at	625	nm	as	measured	by	spectrophotometry	(Bibby	Scientific	
Limited, Staffordshire, UK). Four hundred micro litre of this dilu‐
tion	 was	 mixed	 with	 30	ml	 of	 sterile	Mueller‐Hinton	 agar	 (Oxoid,	
Basingstoke,	 UK)	 and	 poured	 into	 square	 plates	 (Gosselin,	 Borre,	
France). Whatman AA assay discs (Whatman International Limited, 
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Maidstone, UK), soaked in seaweed extract for 24 hr, were dried in 
a	laminar	flow	hood	for	15	min.	Positive	control	(imipenem,	4	mg/L)	
and negative control (60% methanol) discs were soaked and dried 
in	 the	 same	way.	Dry	 discs	were	 placed	 on	 the	 agar	 using	 sterile	
tweezers	 (14	seaweed	extract	discs	and	two	controls	per	plate,	all	
combinations were plated in duplicate). Plates were incubated at 
37°C.	After	18	hr,	 zones	of	 inhibition	 (areas	with	no	visible	bacte‐
rial	growth)	were	measured	for	each	disc.	Inhibition	zone	sizes	were	
recorded	as	total	diameter	minus	size	of	the	diffusion	disc	(5	mm).
2.4 | Minimum inhibitory concentration
Seaweed extracts (200 µl) were evaporated overnight in the first 
column of a 96‐well plate (Starlab Limited, Milton Keynes, UK). A 
twofold dilution range of each extract (200 µl volume) was made in 
nine columns in LB broth, with the remaining two columns used as 
positive	and	negative	controls.	Diluted	bacterial	inoculum	was	added	
to	 a	 final	 concentration	of	5	×	105 CFU/ml. 10 μl alamar blue dye 
(Thermo Fisher Scientific Incorporated, Waltham, USA) was added 
as an indicator of bacterial respiration (growth). Plates were briefly 
agitated	and	incubated	at	37°C	for	18	hr.	Antimicrobial	susceptibil‐
ity	 to	 Tetracycline,	 Oxacillin,	 Cefotaxime,	 Gentamicin,	 Rifampicin	
and Erythromycin (Sigma‐Aldrich, Steinheim, Germany) was tested 
for a subset of strains. Stock solutions (10 mg/ml) were prepared 
in ddH2O	and	filter	sterilized.	A	broth	microdilution	assay	was	per‐
formed in a 96‐well plate as described above, using antibiotic con‐
centrations from 0.1 to 100 mg/L.
2.5 | Genome sequencing, bioinformatics and 
phylogenetic analyses
A	 phenol:chloroform:isoamyl	 alcohol	 DNA	 isolation	 protocol	
modified from Sambrook and Russel (Sambrook, 2006) was used 
to	obtain	genomic	DNA.	DNA	quality	was	visually	assessed	on	a	
1%	agarose	gel,	and	DNA	quality	was	measured	using	Qubit	fluo‐
rometer	(Life	Technologies).	DNA	was	dissolved	in	Elution	Buffer	
(10 mM TRIS, pH8) and sent on dry ice to the University of Exeter 
Sequencing	 Facility.	 Sequencing	 libraries	 were	 run	 on	 a	 Hiseq	
2,500	in	rapid	run	mode	(250	base	pair	paired‐end	reads)	yielding	
between	1.3	and	6	million	reads	per	sample.	Sequencing	data	were	
trimmed	to	remove	sequencing	adaptors	and	low‐quality	terminal	
ends	 (<Q20)	using	 fastq‐mcf	 v1.1.2‐537	 (Aronesty,	 2011).	Reads	
were assembled using SPAdes 3.11.0 (Bankevich et al., 2012) 
and	assessed	using	QUAST	(Gurevich,	Saveliev,	Vyahhi,	&	Tesler,	
2013).	Small	contigs	(<500	base	pairs)	were	removed.	Short	reads	
were	mapped	 to	 the	 reference	 genome	H0	 5096	 0412	 (EMRSA 
15)	 using	 SMALT	 on	 default	 settings	 and	 a	 mean	 insert	 size	 
of 300 bp (http://www.sanger.ac.uk/resources/software/smalt/). 
Reads containing insertions or deletions (indels) were realigned 
using the Genome Analysis Toolkit's IndelRealigner (https://www.
ncbi.nlm.nih.gov/pmc/articles/PMC2928508/).	 Single	 nucleotide	
polymorphisms	(SNPs)	were	called	using	SAMtools	0.1.18	(H.	Li	et	
al., 2009). Variants were filtered using in‐house scripts to include 
only	 SNPs	 with	 >4x	 read	 depth	 per	 base	 (>2	 per	 strand),	 >75%	
support	for	an	alternative	variant,	mapping	quality	>30	and	a	site	
allele	 frequency	of	 the	alternative	allele	of	>0.95.	Samples	were	
sequence	 typed	 using	 ARIBA	 from	 the	 pubMLST	 databases	 ac‐
cessed	on	26	January	2017	(Hunt	et	al.,	2017).	A	maximum‐likeli‐
hood phylogenetic tree was reconstructed for core genomes using 
RAxML	 (Stamatakis,	 2014).	 Consensus	 sequences	 generated	 by	
the variant calling pipeline were passed to RAxML under a gen‐
eral time‐reversible (GTR) model of nucleotide substitution with 
a GAMMA rate of site heterogeneity. A rapid bootstrap analysis 
(100 bootstraps) and search for best‐scoring ML tree were per‐
formed in a single program run.
2.6 | Statistical analyses
Test,	correlation	covariance	and	ANOVA	were	performed	in	R	(ver‐
sion	0.98.1103,	R	Core	Team,	2013;	Team,	2015).	Dedicated	pack‐
ages corrplot and survival were used for survival analysis (Therneau 
&	Lumley,	2015;	Wei	&	Wei,	2015).	The	packages	gplots	(Warnes	et	
al., 2013) and ggplot2 (Wickham, 2009) and lattice (Sarkar & Sarkar, 
2015)	were	used	for	graphics.	To	categorize	the	extracts	into	those	
with nearly constant effect and others with a more variable ef‐
fect, the k‐means algorithm (Bishop, 2006) was used on inhibition 
zone	standard	deviations	with	two	classes	and	the	default	settings	
in	MATLAB	 (Release,	 2012).	 To	maximize	 power	while	 accounting	
for multiple hypothesis testing, a standard permutation test (Gao, 
Becker, Becker, Starmer, & Province, 2010) was used to identify indi‐
vidual extracts in the more variable class with significant association 
between	the	level	of	clinical	 (VITEK)	resistance	and	the	halo	sizes.	
Correlations between the clinical resistance and the average inhibi‐
tion	zone	size	 from	replicate	measurements	 for	each	extract	were	
calculated and tested for significance using 100,000 random permu‐
tations	of	clinical	resistance	values.	Trees	and	figures	were	visualized	
using	the	R	package	ggtree	(Yu,	Smith,	Zhu,	Guan,	&	Lam,	2017).
3  | RESULTS
3.1 | Resistance to seaweed extracts as a function 
of multidrug resistance
A total of 48 species of macroalgae were collected from intertidal 
and shallow subtidal waters in Cornwall, UK (Table S1) and processed 
into	methanolic	extracts	of	standardized	dry	weight	concentration.	
Extracts were used in a disc diffusion assay (Figure S1) to challenge 
28 clinical S. aureus	strains,	each	with	a	unique	clinical	antibiotic	sus‐
ceptibility profile (Table S2). Beta‐lactam resistance was observed 
at	high	 frequency	within	 the	collection:	26	 isolates	were	 resistant	
to	benzylpenicillin.	Fourteen	isolates	were	methicillin	resistant,	and	
all of these MRSA isolates were also resistant to oxacillin and broad 
spectrum cefoxitin. Intermittent resistance to fusidic acid, clindamy‐
cin, erythromycin and tetracycline was observed (Table S2).
27/48	(56%)	of	extracts	showed	activity	against	at	 least	one	S. 
aureus	strain,	as	indicated	by	a	clear	zone	of	growth	inhibition.	A	total	
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of	17	extracts	inhibited	all	28	bacterial	strains,	whereas	ten	extracts	
showed inhibition against a subset of strains (Table S1). Plotting 
the number of clinical antibiotics against the number of seaweed 
extracts each strain was resistant to reveals a significant positive 
correlation (Figure 1; R2 = 0.21, p < 0.01), indicating that on aver‐
age, antimicrobials isolated from natural sources are least effective 
against the most problematic multidrug‐resistant strains. In addition 
to	scoring	presence	or	absence	of	inhibition	zones,	the	effect	of	indi‐
vidual	seaweed	extracts	was	analysed	by	quantifying	inhibition	zone	
sizes.	Inhibition	zone	size	is	significantly	negatively	correlated	with	
the Minimum Inhibitory Concentration (minimum inhibitory concen‐
tration [MIC], the lowest concentration at which bacterial growth is 
inhibited)	based	on	pairing	27	active	extracts	with	the	strain	most	
sensitive to clinical antibiotics (R2 = 0.21, p < 0.01; strain SA2934, 
Figure 2). Strains resistant to a greater number of clinical antibiot‐
ics	showed	a	tendency	to	display	a	smaller	total	inhibition	zone	size	
(sum	of	inhibition	zone	sizes	of	the	27	seaweed	extracts)	(R2 = 0.08, 
p	=	0.07;	Figure	3),	consistent	with	the	data	in	Figure	1.
3.2 | Resistance to individual seaweed extracts as a 
function of multidrug resistance
In order to identify individual extracts that showed a significantly 
positive or negative relationship with overall clinical resistance, 
a	k‐means	algorithm	was	used	on	inhibition	zone	size	standard	de‐
viations to divide extract in a high and a low variance class. The ma‐
jority of extracts (21) show low variation in activity across the panel 
(Figure	4).	Next,	a	permutation	test	was	used	on	the	seven	high	vari‐
ance species (Chaetomorpha melagonium, Ulva lactuca, Cladophora 
rupestris, Ceramium rubrum, Spyridia griffithsiana, Corallina officinalis 
and Plumaria plumosa) to test whether their activity was signifi‐
cantly correlated with clinical resistance as determined by VITEK. 
Three extracts displayed moderately strong negative association 
with	 clinical	 resistance,	 with	 halo	 size	 decreasing	 with	 increasing	
F I G U R E  1   Correlation between clinical resistance (sum of 
22 antibiotics assayed using VITEK technology) and seaweed 
resistance	(sum	of	27	methanolic	extracts)	for	28	S. aureus isolates 
(R2 = 0.21, p < 0.01).
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F I G U R E  2   Correlation between dilution factor and inhibition 
zone	size	for	27	extracts	assayed	on	strain	SA2934	(R2 = 0.21, 
p	<	0.01).	Dilution	factor	is	inversely	proportional	to	Minimal	
Inhibitory Concentration (MIC).
F I G U R E  3   Correlation between resistance against clinical 
antibiotics (assayed using VITEK technology) and seaweed 
resistance	as	quantified	by	the	sum	of	inhibition	zone	sizes	of	
the	27	seaweed	extracts	able	to	inhibit	all	28	S. aureus isolates 
(R2 = 0.08, p	<	0.07).
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clinical resistance, of which two were highly significant (C. rupestris: 
r	=	−0.487,	p = 0.00423; C. rubrum: r	=	−0.463,	p = 0.00681) and one 
borderline nonsignificant (U. lactuca: r	=	−0.306,	 p	=	0.0567).	 No	
extracts were found to have a significantly positive association be‐
tween	inhibition	size	and	clinical	resistance.
3.3 | Cross‐resistance and collateral sensitivity 
patterns between individual seaweed extracts and 
antibiotics
A	more	detailed	analysis	based	on	extract	 inhibition	zone	sizes	for	
27	seaweed	extracts	and	MICs	for	14	different	antibiotics	was	per‐
formed	using	Pearson	correlation	coefficients	(Figure	5).	This	analy‐
sis shows that the activities of some seaweeds across the S. aureus 
panel are similar, suggesting that they produce similar antimicrobial 
compounds. In some cases, seaweed extracts show activity pat‐
terns similar to those of antibiotics, for example, Cystoseira baccata, 
Cystoseira tamariscifolia	and	oxacillin	(Figure	5).	However,	the	oppo‐
site pattern of cross‐resistance, where the activity of antibiotics is 
negatively correlated with the activity of seaweed extracts, also oc‐
curs,	for	example,	benzylpenicillin	and	Jania rubens or ciprofloxacin 
and C. melagonium, C. rubrum and Ascophyllum nodosum (Figure	5).
3.4 | Antimicrobial activity as a function of seaweed 
relatedness
To test whether closely related seaweeds species had similar an‐
timicrobial activity, we focused on the only genus represented by 
three species: Cystoseira (C. tamariscifolia, C. baccata and C. nodicau-
lis). Two of the three species were found to have highly similar ef‐
fects on the panel of 28 S. aureus strains whereas a third species 
F I G U R E  4  Box‐plots	of	inhibition	zone	size	standard	deviations	
for a high and low variance seaweed antimicrobial activity group 
created by the k‐means algorithm with default settings
F I G U R E  5   Pearson correlation 
coefficients between seaweed extract 
inhibition	zone	sizes	and	clinical	antibiotic	
MICs assayed using VITEK technology 
generated on a test panel of 28 S. aureus 
isolates. Colour‐coded values range from 
−1	=	perfect	negative	correlation	(red)	
to 1 = perfect positive correlation (blue); 
the	size	of	the	data	points	co‐varies	with	
colour intensity
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had a noticeably different overall effect, as highlighted by a heatmap 
(Figure	6a).	Differential	 inhibition	could	 in	 theory	be	due	 the	pro‐
duction	of	different	active	compounds	(i.e.,	qualitative	differences)	
or	due	to	differences	in	concentration	of	compounds	(i.e.,	quantita‐
tive	differences)	between	extracts.	By	plotting	inhibition	zone	sizes	
on all 28 S. aureus strains for the three different pairwise extract 
combinations (Figure 6b), it is possible to distinguish between these 
two scenarios. A specific extract can be expected to show the same 
qualitative	effect	on	the	panel	of	bacteria	regardless	of	its	concen‐
tration (i.e., a more diluted extract will show proportionally smaller 
inhibition	zones).	That	there	is	no	significant	correlation	between	the	
outlier species C. nodicaulis and the two other species indicates that 
its	extract	is	qualitatively	different	(Figure	6b).
A previous study demonstrated that of these three Cystoseira spe‐
cies, C. tamariscifolia was the out‐group on the basis of the ITS2 se‐
quence	and	two	physicochemical	methods	(Jégou,	Culioli,	Kervarec,	
Simon, & Stiger‐Pouvreau, 2010). A disc diffusion assay where the 
three Cystoseira extracts were tested against three Gram‐negative 
species confirmed the out‐group position of C. tamariscifolia (Figure 
S2). Together, these findings demonstrate that genetic divergence, 
metabolomic divergence and antagonistic activity on other bacterial 
types	are	not	reliable	indicators	of	antimicrobial	activity.	Differences	
in antagonistic activity were observed for two Fucus species, two 
Ulva species and two Ceramium species, further supporting the ob‐
servation that antimicrobial activity can vary within seaweed genera 
(data not shown).
3.5 | Genomic context of seaweed 
extract resistance
We	obtained	 26	 high‐quality	 S. aureus	 genomic	 sequences,	which	
revealed that a large proportion of known clinical S. aureus diversity 
was	captured,	with	common	sequence	types	(STs)	from	nosocomial	
infections	(ST22;	Holden	et	al.,	2013)	(ST250;	Enright	et	al.,	2002),	
community‐associated	 lineages	 (ST1;	Earls	et	 al.,	 2017),	 (ST59;	Qu	
et al., 2014) and some strains more commonly associated with ag‐
ricultural	 environments	 (ST5;	 Hau	 et	 al.,	 2018)	 (ST1245/CC130;	
Bortolami	et	al.,	2017)	represented	within	the	collection.	The	antibi‐
otic resistance profiles across the phylogenetic diversity of this S. au-
reus collection indicated a range of high and low antibiotic resistance 
isolates, in keeping with the broad population diversity captured 
within	the	collection	 (Fig.	S3).	Visualization	of	the	susceptibility	of	
S. aureus isolates to seaweed extracts alongside the phylogenetic 
tree of the S. aureus sample collection indicated limited genotype–
phenotype clustering with large variation between seaweed extract 
treatments	(Figure	7,	red	=	resistant,	green	=	susceptible).
4  | DISCUSSION
We here, to our knowledge for the first time, demonstrate that bac‐
terial resistance to clinical antibiotics is positively correlated with 
resistance to natural antimicrobials. A subset of seaweed extracts 
showed antimicrobial activity patterns similar to those of clinical 
antibiotics, a pattern that is consistent with cross‐resistance, where 
active compounds are structurally similar and/or target the same 
bacterial pathway (Baker‐Austin et al., 2006). The potential of cross‐
resistance between natural antimicrobials and clinical antibiotics has 
important implications for human health. Recent, careful experimen‐
tation has demonstrated that ecologically relevant concentrations 
of secondary metabolites as exuded in the seaweed‐water bound‐
ary layer can select which bacteria can successfully settle (Lachnit, 
Fischer,	 Künzel,	 Baines,	&	Harder,	 2013;	 Lachnit,	Wahl,	&	Harder,	
2009). Taken together, these findings suggest that seaweeds can se‐
lect	for	colonizing	bacteria	that	are	resistant	to	their	metabolites	and	
that it is possible these same bacteria could also be more resistant 
to clinical antibiotics.
Many human pathogens can be found in environmental reser‐
voirs, with S. aureus able to survive for significant periods in coastal 
waters (Levin‐Edens, Bonilla, Meschke, & Roberts, 2011; Tolba et 
al., 2008). Although the potential for prolonged (co‐)evolution of 
S. aureus in the marine environment might be limited, we note that 
humans could be exposed to a whole range of human pathogens, 
increasing the scope for resistance evolution and exposure. For 
F I G U R E  6  Differences	in	anti‐S. aureus 
activity between three Cystoseira species: 
C. tamariscifolia (CT), C. baccata (CB) and 
C. nodicaulis	(CN)	based	on	the	average	of	
two independent replicates. (a) Heatmap 
showing	inhibition	zone	size	(yellow:	small,	
red: large) for each of the three extracts 
on 28 S. aureus isolates clearly demarcates 
the	CN	extract	as	having	differential	
activity. (b) A correlation matrix plotting 
inhibition	zone	sizes	for	pairs	of	extracts	
on the S. aureus panel
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instance, it has been estimated that there are over six million expo‐
sure events to cephalosporin‐resistant E. coli through recreational 
use of coastal bathing water in England and Wales alone (Leonard, 
Zhang,	 Balfour,	 Garside,	 &	 Gaze,	 2015).	 Increased	 persistence	 of	
multidrug‐resistant pathogens settling on seaweeds in polluted 
coastal waters and possible in situ antibiotic resistance evolution of 
pathogens via mutation or the lateral transfer of resistance genes 
from bacteria native to seaweeds thus warrants further investiga‐
tion. We also note that the potential for any “biotic co‐selection” 
extends beyond seaweeds and the wider marine environment and 
could potentially be mediated by different organisms and in terres‐
trial habitats.
Rather than using bacterial antibiotic‐resistant mutants gener‐
ated through mutational processes in short‐term evolution exper‐
iments (e.g., Imamovic & Sommer, 2013), we used a genomically 
diverse set of pathogenic isolates more representative of resistance 
evolution to test for patterns of cross‐resistance. The antibiotic re‐
sistance profiles indicated a range of high and low resistance iso‐
lates, in keeping with the broad population diversity captured within 
the	collection	 (Figure	S3).	No	clear	congruence	could	be	observed	
between genomic relatedness and seaweed extract resistance. 
Some seaweed extracts showed generally low or high antimicrobial 
activity, but the extracts that showed variation in activity often did 
so across the entire phylogeny (e.g., see the activity of C. melago-
nium, C. officinalis and Cladostephus spongiosus in Figure 6). The un‐
coupling of phylogenetic relatedness and resistance patterns could 
have arisen due to a variety of reasons. The chemically diverse na‐
ture of extracts could mean a wide range of mechanisms underlies 
resistance phenotypes, from more targeted antibiotic‐like activity 
to unspecific biocidal activity. Lateral gene transfer is expected to 
unlink the carriage of genes involved in resistance and overall ge‐
nomic relatedness. However, the fact that resistance is observed 
even within a clonal complex (e.g., ST22, Figure 6) makes divergence 
in resistance due to single point mutations likely as well.
Two extracts showed significantly less activity on strains that 
were more antibiotic resistant. The activity of other extracts 
showed relatively low variation in inhibition across the test panel, 
which in part could be caused by antimicrobial resistance mecha‐
nisms distinct from clinical resistance mechanisms. For instance, 
A. armata showed a particularly low level of variation in activity 
across the test panel; anti‐S. aureus activity of this species has been 
shown to be due to the production of bromoform and dibromoace‐
tic	acid	(Paul,	de	Nys,	&	Steinberg,	2006).	Brominated	compounds	
act	 as	 mutagens	 (DeMarini,	 Perry,	 &	 Shelton,	 1994;	 Kargalioglu,	
McMillan, Minear, & Plewa, 2002) which are not expected to act 
differently in strains with different antibiotic resistance. In a more 
F I G U R E  7  A	maximum‐likelihood	phylogenetic	tree	based	on	whole	genome	sequence	data	of	27	S. aureus genomes used in this 
study	mapped	to	EMRSA15	reference	genome	HO	5,096	0,412	(not	included	in	the	tree)	(2,832,299	bp).	The	panel	on	the	right	indicates	
susceptibility	to	25	seaweed	extracts,	quantified	by	zone	of	inhibition	(red	=	resistant,	no	inhibition;	green	=	susceptible,	high	inhibition).	
Ceramium sp., and A. armata	were	excluded	to	aid	visualization	as	they	produced	extremely	high	inhibition	on	the	majority	of	the	isolates.	
White cells in the figure indicate missing data. The phylogenetic tree was generated using a GTR model of nucleotide substitution and a 
GAMMA model of rate heterogeneity in RaxML
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direct comparison based on individual antibiotics and extracts, di‐
verse patterns of cross‐resistance and collateral sensitivity could be 
observed, suggesting a wide diversity in modes of action and re‐
sistance mechanisms. Collateral sensitivity was observed between 
seaweed extracts and a range of antibiotics, including β‐lactams, 
fluoroquinolones	and	lincosamides.
Humankind has resorted to natural products to treat infec‐
tions	throughout	history	(Harrison	et	al.,	2015),	and	the	majority	
of drugs, including antibiotics, are natural products or have been 
derived from natural products (Butler & Buss, 2006; J. W.‐H. Li 
&	Vederas,	2009).	Decreases	in	profitability	and	biotechnological	
advances have meant that the search for novel pharmaceuticals 
has increasingly been led by high‐throughput screening of syn‐
thetic libraries (Clardy, Fischbach, & Walsh, 2006; J. W.‐H. Li & 
Vederas, 2009). Although modifications of existing structures with 
promising activity are relatively easy to generate and screen, con‐
cerns have been raised about the efficiency of this approach, as 
truly novel modes of actions are unlikely to be discovered (Chopra, 
2012). In contrast, natural products represent a vastly richer bio‐
chemical diversity, which moreover is based on an evolutionary 
history	that	has	optimized	physiological	function	through	natural	
selection (Clardy & Walsh, 2004). Considering that only a single 
bacterial target species was assayed, the prevalence and diversity 
of antimicrobial activity of seaweed extracts confirm the promise 
that natural antimicrobials hold.
We hope that correlational analyses such as employed here can 
be used to facilitate identification of novel extracts bearing promise 
for costly and time‐intensive downstream active compound identifi‐
cation and pharmacological testing. More generally, we contend that 
multidisciplinary approaches combining insights from microbiology, 
evolutionary ecology and ideally biochemistry are necessary to bet‐
ter understand both the potential of novel antimicrobials and the 
threats of antimicrobial resistance in the environment.
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